Ligand Pharmaceuticals Incorporated · NASDAQ:LGND

Reardon Andrew sold 5,000 Ligand Pharmaceuticals Incorporated shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 2, 2026

On Apr 1, 2026, Reardon Andrew (CLO & Secretary) sold 5,000 Ligand Pharmaceuticals Incorporated shares at an average US$201.24 for US$1.01M under a trading plan, leaving 41,382 shares. Filed Apr 2, 2026 (Form 4).

Sold
5,000 shares
Price
US$201.24 average (US$198.85 to US$204.50)
Value
US$1.01M
Holding after
41,382 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CLO & Secretary

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockOption exercise5,000US$52.2746,382Direct
Apr 1, 2026Common StockSale460US$198.8545,922Direct
Apr 1, 2026Common StockSale1,302US$199.7244,620Direct
Apr 1, 2026Common StockSale1,238US$200.9443,382Direct
Apr 1, 2026Common StockSale700US$201.9042,682Direct
Apr 1, 2026Common StockSale963US$203.2241,719Direct
Apr 1, 2026Common StockSale337US$204.5041,382Direct

Source

View original at SEC

Related